Filing Details

Accession Number:
0000791908-13-000043
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-03 16:22:32
Reporting Period:
2013-12-02
Filing Date:
2013-12-03
Accepted Time:
2013-12-03 16:22:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
791908 Xoma Corp XOMA Pharmaceutical Preparations (2834) 942756657
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1222790 Phd Md J Patrick Scannon C/O Xoma Corporation
2910 Seventh Street
Berkeley CA 94710
Exec. Vp & Cso Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2013-12-02 3,335 $1.69 45,352 No 4 M Direct
Common Shares Disposition 2013-12-02 3,335 $6.00 42,017 No 4 S Direct
Common Shares Acquisiton 2013-12-02 16,665 $1.69 58,682 No 4 M Direct
Common Shares Disposition 2013-12-02 16,665 $6.00 42,017 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Incentive Share Option (right to buy) Disposition 2013-12-02 3,335 $1.69 3,335 $1.69
Common Shares Non-Qualified Share Option (right to buy) Disposition 2013-12-02 16,665 $1.69 16,665 $1.69
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
9,939 2013-10-28 2021-10-27 No 4 M Direct
38,406 2013-10-28 2021-10-27 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares 20,339 Indirect by 401(k)
Common Shares 750 Indirect by Daughter
Common Shares 4,053 Indirect by Trust
Footnotes
  1. This transaction was made pursuant to Rule 10b5-1 trading plan adopted by the reporting person on 3/20/2013.